Zhenming Yu

Molecular Assay Development | Genomic Technologies | Precision Medicine | Biomarkers | Molecular Diagnostics | Cell and Gene Therapies

Role
Principal Scientist, Molecular Assay Development and Clinical Genetics and Genomics at Bristol Myers Squibb
Location
Princeton Junction, NJ, US
LinkedIn followers
500 followers

About Zhenming Yu

Extensive experience in genomics assay development in gene therapy and clinical…

Experience

  1. Principal Scientist, Molecular Assay Development and Clinical Genetics and Genomics

    Bristol Myers Squibb

    Nov 2024 — Present · Lawrenceville, NJ, US

    Design and implementation of next-generation sequencing (NGS) and droplet digital PCR (ddPCR) assays for applications in translational research.

Education

  • University of Chinese Academy of Sciences

    Master's degree

  • University of Pennsylvania

    HHMI Postdoctoral Fellow

  • Harvard Medical School

    Other: HMX Pro-Cancer Genomics and Precision Oncology

    2025 — 2025

  • Nankai University

    Bachelor's degree

  • The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences

    Doctor of Philosophy - PhD

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Zhenming Yu — Principal Scientist, Molecular Assay Development and Clinical Genetics and Genomics at Bristol Myers Squibb in Princeton Junction, NJ, US | Unifers